Relay Therapeutics News and Activities
Presence
Relay Therapeutics develops precision medicines for cancer and genetic diseases. It provides drug discovery and drug development services and targeted therapies for patients, healthcare providers, and pharmaceutical partners.
Relay Therapeutics products and services overview:
- Targeted therapies
- Cancer medicines
- Genetic disease drugs
- Drug discovery
- Research partnerships
Revenue: ~$25 million
Employees: 380
Headquarters: Cambridge, United States (USA)
Relay Therapeutics is one of the...
Relay Therapeutics is a company listed under the stock ticker RLAY (US).
Executives
View the org chart displaying its 30 main executives
Most searched biographies at Relay Therapeutics
- Sanjiv Patel, Director, President and Chief Executive Officer
- Alexis Borisy, Executive Chairman of the Board
- Sekar Kathiresan, Director
Popular executive movements at Relay Therapeutics
- Rosario Andre has joined the company as Vice President, Head of International Medical Affairs (posted on March 30 2026).
Create your alert
to follow the executive moves at Relay Therapeutics.
Biotechnology
Relay Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Relay Therapeutics
- Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights | Relay Therapeutics
- Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event | Relay Therapeutics
- Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event | Relay Therapeutics
- Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights | Relay Therapeutics
- Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights | Relay Therapeutics
- Relay Therapeutics Announces Pricing of Initial Public Offering | Relay Therapeutics
- View more press releases Close
Social media about Relay Therapeutics
- Relay Therapeutics on Wikipedia, Google News & Yahoo Finance
- Relay Therapeutics on LinkedIn, X (Twitter) & YouTube
